Cetera Advisor Networks LLC Moderna, Inc. Transaction History

Cetera Advisor Networks LLC

$0
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $1.84 Million - $2.48 Million	21,521 Added 70.48%	52,057 $5.55 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $626,702 - $941,540	9,016 Added 41.9%	30,536 $3.04 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $270,237 - $354,887	2,803 Added 14.98%	21,520 $2.22 Million
Q2 2023 Aug 09, 2023	BUY	$118.5 - $160.53 $234,037 - $317,046	1,975 Added 11.8%	18,717 $2.27 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $61,453 - $89,250	-453 Reduced 2.63%	16,742 $2.57 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $10,299 - $18,273	87 Added 0.51%	17,195 $3.09 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $359,641 - $591,472	-3,046 Reduced 15.11%	17,108 $2.02 Million
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $539,852 - $813,903	4,609 Added 29.65%	20,154 $2.88 Million
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $317,035 - $589,270	-2,507 Reduced 13.89%	15,545 $2.68 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $260,596 - $425,260	1,154 Added 6.83%	18,052 $4.59 Million
Q3 2021 Nov 16, 2021	SELL	$221.9 - $484.47 $45,489 - $99,316	-205 Reduced 1.2%	16,898 $6.5 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $724,118 - $1.31 Million	5,574 Added 48.35%	17,103 $4.02 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $128,286 - $218,526	-1,175 Reduced 9.25%	11,529 $1.51 Million
Q4 2020 Feb 17, 2021	BUY	$65.74 - $169.86 $32,212 - $83,231	490 Added 4.01%	12,704 $1.33 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $267,298 - $466,567	4,919 Added 67.43%	12,214 $864,000
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $216,442 - $583,600	7,295 New	7,295 $468,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Account